DOCSLIB.ORG

A Quiet Revolution: Drug Decriminalisation Across the Globe Niamh Eastwood, Edward Fox & Ari Rosmarin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Quiet Revolution: Drug Decriminalisation Across the Globe Niamh Eastwood, Edward Fox & Ari Rosmarin A QUIET REVOLUTION: DRUG DECRIMINALISATION ACROSS THE GLOBE NIAMH EASTWOOD, EDWARD FOX & ARI ROSMARIN MARCH 2016 THIS PUBLICATION This is the second edition of ‘A Quiet Revolution: Drug Decriminalisation Across the Globe’. The first edition was released in July 2012 and has since been cited by a wide range of organisations and agencies, including: the World Health Organisation, the Office of the United Nations High Commissioner for Human Rights, and the Global Commission on Drug Policy. This edition builds on the 2012 publication, providing updates on the jurisdictions originally covered and highlighting a number of new countries that have adopted a non-criminal justice response to the possession of drugs for personal use. Many countries continue to incarcerate and criminalise people for possession or use of drugs, with criminalisation alone undermining employment, education and housing opportunities. In addition, many people who use drugs are often subject to human rights abuses by the state in jurisdictions which continue to criminalise them. The continued targeting of this group has not only a negative impact on the individuals in question, but their families and broader society as a whole. The aim of this report is to inform the public and policymakers alike on the impact of decriminalising drug possession offences, showing that decriminalisation does not lead to increased rates of use while equally demonstrating that law enforcement- led approaches have little impact on this metric. Rather, the decision to end the criminalisation of people who use drugs can negate the harms highlighted above when done effectively and produce positive social, health and economic outcomes, not just for the individual, but for society as a whole. ACKNOWLEDGEMENTS The authors would like to thank the following people who reviewed the country information to ensure it was accurate and up to date: Aram Barra, Dr. Vendula Belackova, Mariano Fusero, Luciana Pol, Dr. Caitlin Hughes, Professor Tom Decorte, Maria Cristina Meneses Sotomayor, João Augusto Castel-Branco Goulão, Pablo Cuevas, Sergio Sánchez Bustos, Ana Maria Rueda, Marco Perduca, Pien Metaal, Ana Sofia Santos, Raymond Pryce, Tom Blickman, Bill Piper, Lynne Lyman, Stephen Gutwillig, Demaluí Amighetti López, Milton Romani Gerner, Ivan Varentsov, Luis Eduardo Sandí Esquivel, Professor Alex Stevens, Agnieszka Sieniawska, Christine Kluge Haberkorn, Magdalena Dabkowska, Joanne Csete, Diane Steber. Finally, thank you to Amber Marks for drafting and reviewing the section on Spain. Her expertise on this country is invaluable. DONORS Thanks to Open Society Foundations and to The Esmée Fairbairn Foundation for funding this publication. 3 A QUIET REVOLUTION AUTHORS NIAMH EASTWOOD Niamh is the Executive Director of Release. Niamh has extensive experience of service delivery, policy strategy, and operational development and has co-authored Release’s two previous policy papers, ‘The Numbers in Black And White: Ethnic Disparities in the Policing and Prosecution of Drug Offences in England and Wales’, and the first edition of ‘A Quiet Revolution’. Niamh is also responsible for drafting many of Release’s briefings for Parliamentarians and policymakers, has presented at international and national conferences and is regularly invited to comment in the media. More recently Niamh co-authored an Amicus Curiae that was submitted in relation to the successful Mexican Supreme Court challenge to national cannabis laws, and served as technical advisor to the Global Commission on Drug Policy. EDWARD FOX Edward is Release’s Policy and Communications Manager, having previously worked as a journalist and editor in Colombia for InSight Crime. He served as technical advisor on the latest Global Commission on Drug Policy report, is regularly invited to comment in the media, has guest lectured at the University of London on drug policy and human rights, presented at national and international conferences and European Parliamentary briefings, and engages in developing Release’s policy briefings and research. ARI ROSMARIN Ari Rosmarin is the Public Policy Director at the American Civil Liberties Union of New Jersey, where he manages the ACLU-NJ’s legislative and policy advocacy work throughout the state. His work covers a broad array of civil rights and liberties issues, and is currently involved in campaigns to reform police practices, strengthen immigrants’ rights, and legalise, tax, and regulate cannabis for adults. Prior to joining the ACLU-NJ, Ari was the Senior Advocacy Coordinator at the New York Civil Liberties Union, where he led campaigns on drug sentencing reform, privacy rights, and post-9/11 government surveillance, among other issues. He has written various articles on drug policy reform in both the U.S. and the U.K. While in law school, he worked with Release in the summer of 2011 where he served as a co-author on the first edition of ‘A Quiet Revolution’. Ari received his B.A. from Columbia University and his J.D. from Brooklyn Law School, where he was an Edward V. Sparer Public Interest Law Fellow. 4 A QUIET REVOLUTION CONTENTS Introduction 6 Considerations for Implementing an Effective Decriminalisation Model 9 Decriminalisation systems by country 13 - Argentina 13 - Armenia 13 - Australia 14 · South Australia 14 · Australian Capital Territory (ACT) 15 · Northern Australia 15 · Western Australia 15 · Drug diversion schemes 16 · Australia: Conclusions 17 - Belgium 17 - Chile 18 - Colombia 18 - Costa Rica 19 - Croatia 19 - Czech Republic 20 - Ecuador 21 - Estonia 22 - Germany 22 - Italy 22 - Jamaica 24 - Mexico 24 - The Netherlands 25 - Paraguay 27 - Peru 27 - Poland 27 - Portugal 28 - The Russian Federation 30 - Spain 31 - Switzerland 33 - United States of America 34 · California 35 · Washington D.C. 36 - Uruguay 36 Conclusion 38 References 39 5 A QUIET REVOLUTION INTRODUCTION Over 50 years since the foundation of the current autonomy, and mounting evidence of the devastating global drug policy regime was laid, prohibitionist consequences of criminal justice responses to drugs drug laws continue to inflict countless harms. An for individuals – stigmatisation, employment decline, estimated $100 billion is being pumped annually into housing issues, and public health harm, among law enforcement-led approaches around the world others – have led a number of countries towards to combat drugs1, with the results mainly involving an alternative policy option: the decriminalisation the criminalisation and incarceration of low-level, of drug possession and use. Under these regimes, nonviolent drug offenders. Indeed, an estimated the possession of small amounts of illicit drugs for 83 per cent of all drug-related offences worldwide are personal use is no longer a criminal offence. 6 simple possession offences.2 To call decriminalisation a new option is misleading. In spite of this undue emphasis on tackling drug use, Some countries have had decriminalisation policies the number of adults globally who have used drugs in place since the early 1970s, while others never increased almost 20 per cent between 2006 and criminalised drug use and possession to begin with. 2013 from 206 million to 246 million,3 underscoring how punitive approaches do not serve as a deterrent. However, in the past 15 years, a new wave of Rather, they help swell prison populations, stoke the countries have moved toward the decriminalisation spread of blood-borne viruses and other infectious model, suggesting growing recognition of the failures diseases and contribute to the shameful level of of the criminalisation approach and a strengthening drug-related deaths, which in 2013 stood at close to political wind blowing in the direction of an historic 200,000 globally.4 paradigm shift. The aforementioned are just a select few of the myriad The models of decriminalisation vary considerably – harms caused by criminalisation. As highlighted in some countries adopt a de jure model (one defined our 2013 report, The Numbers in Black and White: by law), others have de-prioritised the policing of Ethnic Disparities in the Policing and Prosecution drug possession through de facto decriminalisation. of Drug Offences in England and Wales,5 drug laws Furthermore, there is enormous geographical are often imposed most harshly against ethnic variance, with countries as disparate as Armenia, minority communities despite prevalence rates Belgium, Czech Republic, Ecuador, Estonia, Mexico, among these groups being no higher than among the Portugal and parts of the United States all adopting white population. This disproportionality is reflected or extending some form of decriminalisation within elsewhere in the world, particularly the United States their jurisdictions in the last 15 years or so. where it has resulted in the mass incarceration of African Americans. Such a policing approach has had While the precise number of countries with formal serious implications for community-police relations in decriminalisation policies is not clear, it is likely many parts of the world. slightly above 30,7 depending on which definitions are used. Additionally, at the time of writing, Ireland was However, cracks are beginning to emerge in the exploring the decriminalisation of all drugs along the prohibitionist consensus, both in rhetoric and in lines of the model implemented in Portugal. practice. Across the globe governments are adopting different policy approaches to address drug use Decriminalisation has received considerable in their communities – some are reducing harsh
Load more

Recommended publications
  • Special Report on ASX-Listed Cannabis and Hemp Stocks
    Special Report on ASX-listed Cannabis and Hemp stocks An exciting new sector 24 March 2020 From humble beginnings in Canada around ten years ago the cannabis and hemp industries have blossomed into a major force to be reckoned with by investors the world over. Australia is no exception, with many cannabis and hemp companies having gone live on ASX over the last five years. However, many investors are unfamiliar with the dynamics of this exciting new sector. Pitt Street Research now seeks to close that information gap with our Special Report on Cannabis and Hemp, released 24 March 2020. Welcome to the cannabis and hemp revolution Cannabis and hemp have fuelled a major investment boom since 2014 largely because of the known therapeutic benefits of medicinal cannabis. Governments around the world have responded to the scientific evidence and made it easier for patients to access cannabis-based medicine. Concurrently, voters in many countries have become more favourably disposed towards the legalisation of recreational cannabis. These two trends have fuelled a boom in cannabis, while hemp, from a different plant, had also benefited as investors have moved to use this plant for a variety of purposes, most notably in food. It’s fair to say that cannabis and hemp have quickly become respectable industries worthy of investor attention. Many have come to the view that cannabis and hemp are agents of serious economic change, with potential to seriously disrupt Subscribe to our research HERE sectors as diverse as drinks, building materials and, of course, medicine. Analyst: Stuart Roberts Why should the Canadians have all the fun? Tel: +61 (0)447 247 909 Canada was the origin of the current cannabis and hemp boom because the regulatory framework changed in that [email protected] country around 2013 in a way that allowed entrepreneurs to flourish while the public equity markets allowed large amounts of capital to be raised.
    [Show full text]
  • Actors and Incentives in Cannabis Policy Change: an Interdisciplinary Approach to Legalization Processes in the United States and in Uruguay
    1 UNIVERSIDADE DE SÃO PAULO INSTITUTO DE RELAÇÕES INTERNACIONAIS Fernanda Mena Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay São Paulo 2020 FERNANDA MELLO MENA 2 Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Original Version Ph.D. Thesis presented to the Graduate Program in International Relations at the International Relations Institute, Universidade de São Paulo, Brazil, to obtain the degree of Doctor in Science. Advisor: Prof. Dr. Leandro Piquet Carneiro São Paulo 2020 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. 3 Catalogação na Publicação* Instituto de Relações Internacionais da Universidade de São Paulo Mena, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay / Fernanda Mello Mena -- Orientador Leandro Piquet Carneiro. São Paulo: 2020. 195p. Tese (doutorado). Universidade de São Paulo. Instituto de Relações Internacionais. 1. Relações exteriores (História) – Brasil 2. Relações internacionais (História) - Brasil 3. Política externa – Brasil I. Mena, Fernanda II. Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay CDD 327.81 4 MENA, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Ph. D. Thesis presented to the International Relations Institute, at the University of São Paulo, Brazil, to obtain the degree of Doctor in Science.
    [Show full text]
  • WHO Expert Committee on Drug Dependence Pre-Review ……………
    WHO Expert Committee on Drug Dependence Pre-Review …………….. Cannabis plant and cannabis resin Section 5: Epidemiology This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization 1 © World Health Organization 2018 All rights reserved. This is an advance copy distributed to the participants of the 40th Expert Committee on Drug Dependence, before it has been formally published by the World Health Organization. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.
    [Show full text]
  • Cannabis Dictionary
    A MEDICAL DICTIONARY, BIBLIOGRAPHY, AND ANNOTATED RESEARCH GUIDE TO INTERNET REFERENCES JAMES N. PARKER, M.D. AND PHILIP M. PARKER, PH.D., EDITORS ii ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright 2003 by ICON Group International, Inc. Copyright 2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1 Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation.
    [Show full text]
  • Initial Considerations for the Creation of an Inter-Regional Industrial Hemp Value Chain Between Malawi and South Africa
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Lowitt, Sandy Working Paper Initial considerations for the creation of an inter- regional industrial hemp value chain between Malawi and South Africa WIDER Working Paper, No. 2020/23 Provided in Cooperation with: United Nations University (UNU), World Institute for Development Economics Research (WIDER) Suggested Citation: Lowitt, Sandy (2020) : Initial considerations for the creation of an inter- regional industrial hemp value chain between Malawi and South Africa, WIDER Working Paper, No. 2020/23, ISBN 978-92-9256-780-4, The United Nations University World Institute for Development Economics Research (UNU-WIDER), Helsinki, http://dx.doi.org/10.35188/UNU-WIDER/2020/780-4 This Version is available at: http://hdl.handle.net/10419/229247 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte.
    [Show full text]
  • CBD Sixth National Report
    Australia’s Sixth National Report to the Convention on Biological Diversity 2014 2018 ‒ 24 March 2020 © Commonwealth of Australia 2020 Ownership of intellectual property rights Unless otherwise noted, copyright (and any other intellectual property rights) in this publication is owned by the Commonwealth of Australia (referred to as the Commonwealth). Creative Commons licence All material in this publication is licensed under a Creative Commons Attribution 4.0 International Licence except content supplied by third parties, logos and the Commonwealth Coat of Arms. Inquiries about the licence and any use of this document should be emailed to [email protected]. Cataloguing data This report should be attributed as: Australia’s Sixth National Report to the Convention on Biological Diversity 2014‒2018, Commonwealth of Australia, Canberra, 2020 CC BY 4.0. ISBN 978-1-76003-255-5 This publication is available at http://www.environment.gov.au/biodiversity/international/un-convention-biological-diversity. Department of Agriculture, Water and the Environment GPO Box 858 Canberra ACT 2601 Telephone 1800 900 090 Web awe.gov.au The Australian Government acting through the Department of Agriculture, Water and the Environment has exercised due care and skill in preparing and compiling the information and data in this publication. Notwithstanding, the Department of Agriculture, Water and the Environment, its employees and advisers disclaim all liability, including liability for negligence and for any loss, damage, injury, expense or cost incurred by any person as a result of accessing, using or relying on any of the information or data in this publication to the maximum extent permitted by law.
    [Show full text]
  • Programme & Abstracts
    The 57th Annual Meeting of the International Association of Forensic Toxicologists. 2nd - 6th September 2019 BIRMINGHAM, UK The ICC Birmingham Broad Street, Birmingham B1 2EA Programme & Abstracts 1 Thank You to our Sponsors PlatinUm Gold Silver Bronze 2 3 Contents Welcome message 5 Committees 6 General information 7 iCC maps 8 exhibitors list 10 Exhibition Hall 11 Social Programme 14 opening Ceremony 15 Schedule 16 Oral Programme MONDAY 2 September 19 TUESDAY 3 September 21 THURSDAY 5 September 28 FRIDAY 6 September 35 vendor Seminars 42 Posters 46 oral abstracts 82 Poster abstracts 178 4 Welcome Message It is our great pleasure to welcome you to TIAFT Gala Dinner at the ICC on Friday evening. On the accompanying pages you will see a strong the UK for the 57th Annual Meeting of scientific agenda relevant to modern toxicology and we The International Association of Forensic thank all those who submitted an abstract and the Toxicologists Scientific Committees for making the scientific programme (TIAFT) between 2nd and 6th a success. Starting with a large Young Scientists September 2019. Symposium and Dr Yoo Memorial plenary lecture by Prof Tony Moffat on Monday, there are oral session topics in It has been decades since the Annual Meeting has taken Clinical & Post-Mortem Toxicology on Tuesday, place in the country where TIAFT was founded over 50 years Human Behaviour Toxicology & Drug-Facilitated Crime on ago. The meeting is supported by LTG (London Toxicology Thursday and Toxicology in Sport, New Innovations and Group) and the UKIAFT (UK & Ireland Association of Novel Research & Employment/Occupational Toxicology Forensic Toxicologists) and we thank all our exhibitors and on Friday.
    [Show full text]
  • Report of the International Narcotics Control Board for 2020 (E/INCB/2020/1) Is Supplemented by the Following Reports
    INTERNATIONAL NARCOTICS CONTROL BOARD Report 2020 EMBARGO Observe release date: Not to be published or broadcast before Thursday 25 March 2021, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board for 2020 TheReport of the International Narcotics Control Board for 2020 (E/INCB/2020/1) is supplemented by the following reports: Celebrating 60 Years of the Single Convention on Narcotic Drugs of 1961 and 50 Years of the Convention on Psychotropic Substances of 1971 (E/INCB/2020/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2021 — Statistics for 2019 (E/INCB/2020/2) Psychotropic Substances: Statistics for 2019 — Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Sub- stances of 1971 (E/INCB/2020/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psycho tropic Substances: Report of the International Narcotics Control Board for 2020 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2020/4) The updated lists of substances under international control, comprising narcotic drugs, psycho­ tropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E­1339 P.O.
    [Show full text]
  • The Canadian Cannabis Story
    A Generational Investment Opportunity THE CANADIAN CANNABIS STORY JOIN THE CONVERSATION / Echelon Wealth Partners echelonpartners.com TABLE OF CONTENTS 3 The Canadian Cannabis Story: A Generational Investment Opportunity 4 Cannabis: A Brief History 5 The Many Forms of Cannabis 5 An Increase in Legal Cannabis-based Products 5 Medical Use 8 Cannabis as an Opiod Alternative 11 Cannabis and Canada: A Strong Growth Story 14 A Global Cannabis Boom: The Next Stage 17 Canadian Cannabis Stocks - An Investment Opportunity to Consider 19 Endnotes echelonpartners.com 2 The Canadian Cannabis Story: A Generational Investment Opportunity THE CANADIAN CANNABIS STORY: A GENERATIONAL INVESTMENT OPPORTUNITY By Echelon Wealth Partners The Canadian Cannabis Story aims to provide readers with a comprehensive look at the cannabis market in Canada through its history, growth, and various production sectors to illuminate the investment opportunity this sector will afford in a rapidly growing global market. The increasing trend in cannabis decriminalization and legalization, both in North America and around the world, has awakened the interest of the investment community. The unique and potential medicinal properties of cannabis and its versatility for other commercial uses are considered the harbingers of an investment with significant growth potential. Canada legalized marijuana for recreational use on October 17, 2018 echelonpartners.com 3 The Canadian Cannabis Story: A Generational Investment Opportunity CANNABIS A Brief History Marijuana is produced from the flower and leaves of cannabis plants, which grow naturally in humid temperate conditions on all continents.1 The two most important varieties of the cannabis plant are sativa and indica, with hemp being a specific species of the sativa plant.
    [Show full text]
  • Considering Marijuana Legalization
    Research Report Considering Marijuana Legalization Insights for Vermont and Other Jurisdictions Jonathan P. Caulkins, Beau Kilmer, Mark A. R. Kleiman, Robert J. MacCoun, Gregory Midgette, Pat Oglesby, Rosalie Liccardo Pacula, Peter H. Reuter C O R P O R A T I O N For more information on this publication, visit www.rand.org/t/rr864 Published by the RAND Corporation, Santa Monica, Calif. © Copyright 2015 RAND Corporation R® is a registered trademark. Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. Support RAND Make a tax-deductible charitable contribution at www.rand.org/giving/contribute www.rand.org Preface Marijuana legalization is a controversial and multifaceted issue that is now the subject of seri- ous debate. In May 2014, Governor Peter Shumlin signed Act 155 (S.
    [Show full text]
  • Annex 1 Current Encod Membership – April 2014
    ANNEX 1 CURRENT ENCOD MEMBERSHIP – APRIL 2014 HARM REDUCTION ORGANISATIONS - 6 ASSOCIAZIONE TILT – Italy AILAKET - Spain COLLETIVO INFOSHOCK – Italy Akzept e.V. - Germany DRUG PEACE INSTITUTE - Netherlands ALICE-PROJECT - Germany FHN – Norway Blue Point Drug Counseling and Outpatient Center – Forum Droghe – Italy Hungary INEIDFO - Germany BUNDESVERBAND DER ELTERN – Germany LEGALIZACE.CZ – Czech Republic FEDERACION ANDALUZA DE DROGODEPENDENCIAS LEGALIZE! – Netherlands Y SIDA ENLACE - Spain Liaison Antiprohibitioniste – Belgium Meres pour la Marijuana - France CONSUMER ORGANISATIONS, CANNABIS - 40 Netherlands Drug Policy Foundation - The Netherlands ACMEFUER – Spain Norml France – France AICC CANNABISCAFE – Spain Norml UK - UK AIRAM - Spain SNARROTIN – Iceland ALACANNABIS – Spain TILT ROMA - Italy ASARTE CLUB SOCIAL CANNABIS – Spain VEREIN LEGALIZE – Austria Asbl Sativa - Belgium VOC - Netherlands Asociación Club Calidad de Vida – Spain Asociación Casa María – Spain MEDIA - 9 Asociación Kali Club – Spain Cañamo – Spain ASSOCIAZIONE ASCIA - Italy Cannabis Magazine – Spain Bündnis Hanfparade e.V. - Germany Cannaclopedia - Belgium CANNABIS COLLEGE – Netherlands CANNAWEB.CH - Switzerland CANNABIS SANS FRONTIERES – France CANNAWEED – France Cannabis Social Club Maribor - Slovenia CANNAZINE – United Kingdom Chanvre et Libertés – France GONZOMEDIA - Netherlands CIRC NORD EST - France Radio K Centrale – Italy CLUB SOCIAL DE CANNABIS DE GRAZALEMA – Spain The Stoned Society - Netherlands CSC MA WEED PERSO - Belgium Deutscher Hanf Verband – Germany
    [Show full text]
  • Police and Crime Commissioners
    Police and Crime Commissioners : emerging 'drug policy actors'? AUSTEN, Liz <http://orcid.org/0000-0002-2837-8297> Available from Sheffield Hallam University Research Archive (SHURA) at: http://shura.shu.ac.uk/11365/ This document is the author deposited version. You are advised to consult the publisher's version if you wish to cite from it. Published version AUSTEN, Liz (2016). Police and Crime Commissioners : emerging 'drug policy actors'? Safer Communities, 15 (1), 4-10. Copyright and re-use policy See http://shura.shu.ac.uk/information.html Sheffield Hallam University Research Archive http://shura.shu.ac.uk Police and Crime Commissioners: Emerging 'drug policy actors'? Dr Liz Austen Sheffield Hallam University Safer Communities: Viewpoint Article Pre-publication draft Abstract Purpose In 2013, the Police and Crime Commissioner for Durham, Ron Hogg, initiated a debate around the future of British drug policy. In June 2015, the Derbyshire PCC, Alan Charles, opened a similar debate with representatives from policing, third party support agencies, national advocates and academics to discuss the possibilities for change. This short article presents the views and actions of senior figures in the police service and discusses motivations for pursuing change. The aim of the paper is to introduce Police and Crime Commissioners as 'drug policy actors' (Seddon 2011) and to highlight key areas for further academic enquiry. Design/methodology/approach This article is based on press releases and media accounts of the recent activity of the PCCs in relation to national drug policy. This article provides an academic viewpoint on recent events, supported by theoretical literature critiquing drug policy and contemporary policing.
    [Show full text]